Morgan Stanley analyst Tejas Savant upgraded PhenomeX to Equal Weight from Underweight with a $1 price target after the company signed a definitive agreement for Bruker to acquire it for $1.00 per share in an all-cash transaction.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CELL:
